Skip to main content

Intravenous Therapy!

 INTRAVENOUS THERAPY

Definition:

"Intravenous therapy or IV therapy is the giving of liquid substances into vein". 

  • It can be intermittent or continuous; continuous administration called an Intravenous drip. 
  • The word intravenous simply means "within vein" but is most commonly used to refer to IV therapy.
  • Compared to other routes of administration, the intravenous route is the fastest way to deliver fluids and medications throughout the body. Some medications, as well as blood transfusions and lethal injections can only be given intravenously.
  • The simplest form of intravenous access is a syringe with an attached hole in needle. The needle is inserted through the skin into a vein, and the contents of the syringe are injected through the needle into the bloodstream. This is easily done with an arm vein, especially one of the metacarpal veins.
  • Usually, it is necessary to use a constricting band first to make the vein bulge; once needle is in place, it is common to draw back slightly on the syringe to aspirate blood, thus verifying that the needle is really in the vein; then constricting band is removed before injecting. It is a convenient way to deliver life-saving medications in an emergency. However, in a controlled healthcare setting, direct injection is rarely used since it only allows delivery of a small dose of medication.



Uses of IV Therapy:

  1. Establish or maintain fluid and electrolyte balance.
  2. Administer medication continuously or intermittently.
  3. Administer bolus medication.
  4. Administer blood or blood products.
  5. Administer intravenous anesthetics.
  6. Administer diagnostic reagent.
  7. Correct acidosis or alkalosis.
  8. Monitor hemodynamic function.


Portable Ports:

  • A port often referred to by brand names such as Port-a-Cath or Medi Port; is a central venous line that does not have an external connector; instead, it has a small reservoir implanted under the skin.
  • Medication is administered intermittently by placing a small needle through the skin into the reservoir.
  • Ports cause less inconvenience and have a lower risk of infection and are therefore commonly used for patients on long-tern intermittent treatment.
  • Blood can be drawn from a peripheral IV line, if necessary, but only if it is in a relatively large vein and only if the IV line is newly inserted.
  • Blood draws are typically taken with specialized IV access sets known as phlebotomy kits, and once the draw is complete, the needle is removed, and the site is not used again. If a patient needs frequent venous access, the veins may scar and narrow, making any future access extremely difficult or impossible; this situation is known as a "blown vein", and the person attempting to obtain the access must find a new access site proximal to the "blown" area.


Intravenous Drip:

  • An IV drip is the continuous infusion of fluids, with or without medications, through an IV access device. This may be to correct dehydration or an electrolyte imbalance, to deliver medications, or for blood transfusions.

IV Fluids:

  • Intravenous fluids provide volume replacement and administer medications, including electrolytes.

Labels:

Comments

Post a Comment

Popular posts from this blog

General Mechanism of Actions of INSULIN.

GENERAL MECHANISM OF ACTION OF INSULIN AND RELATE HORMONES The body's main fuel is Glucose. Glucose is stored in the liver and muscles as Glycogen.  Excess glucose is stored in the adipose tissues which yield fatty acids via lipolysis. In the fasting state, free fatty acids supply much of the energy needs of the body except for the CNS which requires Glucose to function normally. Proteins can also be converted to glucose via gluconeogenesis. RELEASE OF INSULIN AND GLUCAGON Insulin and Glucagon are produced in the pancreas by the Islets of Langerhans . Beta cells   make up 70%-90% of the Islets and produce Insulin and Amylin while the a-cells   produce glucagon. The main function of insulin is to decrease blood glucose levels. Glucagon, along with other counter-regulatory hormones such as growth factor, cortisol, and Epinephrine, increases Blood glucose levels.  The opposing actions of Glucagon and Insulin along with other counter-regulatory hormones maintain a norma...
Post a Comment
Read more

Diabetes Mellitus: Its Goals Of Therapy!

  GOAL OF THERPY The goals of treatment of DM includes; Reducing, controlling and managing long-term microvascular, macrovascular and neuropaathic complications. Preserving beta cell function. Preventing acute complications from increased Blood glucosel level. Minimizing hypoglycemic episodes. Maintaining patient quality of life. --Two landmark trials, THE DIABETES CONTROL AND COMPLICATION TRIAL (DCCT) and THE UNITED KINGDOM PROSPECTIVE DIABETES STUDY(UKPDS), showed that lowering blood glucose levels decreased the risk of developing chronic complications. --A near normal blood glucose level can be achieved with appropriate patient education , lifestyle modification and medications . --Proper care of DM requires goal setting and assessment for glycemic control , self-monitoring of blood glucose (SMBG) monitoring of blood glucose pressure , and lipid levels , regular monitoring for the development of complications , dietary and exercise lifestyle modifications and proper medicatio...
Post a Comment
Read more

Diabetes Mellitus: Pharmacotherapy- Gliptins and a-Glycoside Inhibitors!

  PHARMACOTHERAPY:  Medications classifications include:  Sulfonyl Urea's Nonsylfonylurea Secretagogues (a-Glinides) Biguanides Thiazolidinediones a-Glucosidase Inhibitors Dipeptidyl Peptidase-4 Inhibitors (Gliptins) Sodium-glucose co-transporter (SGLT) Inhibitors  Central-Acting Dopamine Agonists Bile Acid Sequestrants Insulin therapy 5. a-GLUCOSIDASE INHIBITORS Acarbose and Miglitol are a-glucosidase inhibitors currently approved in the United States. Mechanism of Action: An enzyme that is along the brush border of the intestine cells called a-glucosidase; breaks down the complex carbohydrates into simple sugars, resulting in absorption. The a-glucosidase inhibitors work by delaying the absorption of carbohydrates from the intestinal tract, which reduces the rise in postprandial glucose levels. Therapy: As a monotherapy , a-glucosidase inhibitors primarily reduce post-prandial glucose excursions.  Clinical Use: FPG concentrations have been decreased by 40-5...
Post a Comment
Read more